Low-normal Systolic Blood Pressure and Secondary Stroke Risk
Overview
Neurology
Authors
Affiliations
A recent observational study of >20,000 patients with recent ischemic stroke suggested that systolic blood pressure (SBP) maintained in a low-normal range may be associated with increased risk of recurrent stroke, especially within the first 6 months after the first stroke. Using a distinct cohort, the current study aimed to independently evaluate the relationship between low-normal SBP levels and risk of recurrent stroke through analysis of a trial dataset involving 3680 patients with recent noncardioembolic ischemic stroke aged ≥ 35 years recruited from 56 centers between September 1996 and May 2003 and followed for 2 years. Subjects were categorized based on their mean in-trial SBP value as low-normal (<120 mm Hg), high-normal (120 to <140 mm Hg), or high (>140 mm Hg). The primary outcome was stroke. Multivariate analyses used competing-risks Cox regression models. The rate of recurrent stroke was 9.1% in the low-normal group, 6.7% in the high-normal group, and 10% in the high group. The difference in recurrent stroke rate between the low-normal and high-normal groups was more prominent within the first 6 months (low-normal, 4.5%; high-normal, 2.5%; high, 3.4%) than after 6 months (low-normal, 4.6%; high-normal, 4.2%; high, 6.6%). Over the study period, compared with the high-normal group, the risk of the primary outcome trended higher in the low-normal group (adjusted hazard ratio, 1.47; 95% confidence interval, 0.94-2.29; P = .09) and was higher in the high group (adjusted hazard ratio, 1.39; 95% confidence interval, 1.08-1.79; P = .01). These results support the recently described pattern of increased risk of recurrent stroke in patients with low-normal SBP levels, especially within the first 6 months after first stroke. However, this study likely was not sufficiently powered to detect more than a strong statistical trend underlying this relationship.
Wardlaw J, Chabriat H, de Leeuw F, Debette S, Dichgans M, Doubal F Eur Stroke J. 2024; 9(1):5-68.
PMID: 38380638 PMC: 10916806. DOI: 10.1177/23969873231219416.
Hsu C, Saver J, Ovbiagele B, Wu Y, Cheng C, Lee M JAMA Neurol. 2023; 80(5):506-515.
PMID: 36939729 PMC: 10028545. DOI: 10.1001/jamaneurol.2023.0218.
The J-Curve Association Between Blood Pressure and Mortality in Stroke Survivors.
Yin T, Cheang I, Zhu X, Liao S, Zhang H, Li X Int J Gen Med. 2021; 14:5039-5049.
PMID: 34511987 PMC: 8412835. DOI: 10.2147/IJGM.S326301.
Jing L, Tian Y, Ren G, Zhang L, Shi L, Dai D BMC Public Health. 2021; 21(1):1648.
PMID: 34503467 PMC: 8427863. DOI: 10.1186/s12889-021-11692-x.
Towfighi A, Cheng E, Ayala-Rivera M, Barry F, McCreath H, Ganz D JAMA Netw Open. 2021; 4(2):e2036227.
PMID: 33587132 PMC: 7885035. DOI: 10.1001/jamanetworkopen.2020.36227.